Compare TTK HEALTHCARE with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs STRIDES PHARMA SCIENCE - Comparison Results

STRIDES PHARMA SCIENCE 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE STRIDES PHARMA SCIENCE TTK HEALTHCARE/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 24.8 8.4 294.9% View Chart
P/BV x 1.7 1.0 169.0% View Chart
Dividend Yield % 0.9 0.5 188.1%  

Financials

 TTK HEALTHCARE   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
STRIDES PHARMA SCIENCE
Mar-18
TTK HEALTHCARE/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs1,2151,147 105.9%   
Low Rs610642 95.0%   
Sales per share (Unadj.) Rs444.4317.2 140.1%  
Earnings per share (Unadj.) Rs17.27.8 219.9%  
Cash flow per share (Unadj.) Rs27.625.1 110.3%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.50.2 245.1%  
Book value per share (Unadj.) Rs177.9274.3 64.9%  
Shares outstanding (eoy) m14.1389.50 15.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.12.8 72.8%   
Avg P/E ratio x52.9114.0 46.4%  
P/CF ratio (eoy) x33.035.7 92.5%  
Price / Book Value ratio x5.13.3 157.2%  
Dividend payout %29.025.5 113.7%   
Avg Mkt Cap Rs m12,89480,058 16.1%   
No. of employees `0002.32.5 92.2%   
Total wages/salary Rs m1,3074,341 30.1%   
Avg. sales/employee Rs Th2,715.711,325.8 24.0%   
Avg. wages/employee Rs Th565.31,731.4 32.7%   
Avg. net profit/employee Rs Th105.4280.1 37.6%   
INCOME DATA
Net Sales Rs m6,27928,394 22.1%  
Other income Rs m78941 8.2%   
Total revenues Rs m6,35629,334 21.7%   
Gross profit Rs m4963,965 12.5%  
Depreciation Rs m1471,540 9.5%   
Interest Rs m341,962 1.7%   
Profit before tax Rs m3931,403 28.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-168 0.0%   
Extraordinary Inc (Exp) Rs m0-436 0.0%   
Tax Rs m14997 153.0%   
Profit after tax Rs m244702 34.7%  
Gross profit margin %7.914.0 56.5%  
Effective tax rate %37.96.9 547.0%   
Net profit margin %3.92.5 157.0%  
BALANCE SHEET DATA
Current assets Rs m2,71724,836 10.9%   
Current liabilities Rs m1,57118,993 8.3%   
Net working cap to sales %18.320.6 88.7%  
Current ratio x1.71.3 132.3%  
Inventory Days Days3271 45.3%  
Debtors Days Days47113 41.1%  
Net fixed assets Rs m99134,289 2.9%   
Share capital Rs m141895 15.8%   
"Free" reserves Rs m2,37323,651 10.0%   
Net worth Rs m2,51424,546 10.2%   
Long term debt Rs m315,513 0.0%   
Total assets Rs m4,15865,437 6.4%  
Interest coverage x12.61.7 735.6%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x1.50.4 348.0%   
Return on assets %6.74.1 163.9%  
Return on equity %9.72.9 338.9%  
Return on capital %16.96.9 245.7%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22515,697 1.4%   
Fx outflow Rs m71735 9.7%   
Net fx Rs m15414,962 1.0%   
CASH FLOW
From Operations Rs m1731,871 9.3%  
From Investments Rs m975,826 1.7%  
From Financial Activity Rs m-307-10,157 3.0%  
Net Cashflow Rs m-38-2,615 1.4%  

Share Holding

Indian Promoters % 65.4 27.7 236.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 37.8 9.8%  
FIIs % 5.2 8.6 60.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 25.9 99.6%  
Shareholders   12,723 56,241 22.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT  SUN PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Buzz on the Street: A Look at Stocks, Sectors and the Economy(Podcast)

The stock markets in India remained rangebound this week. Economic data releases and third quarter results announcements were the focus of the week.

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

How to Buy the Best Safe Stocks in 2020(The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 24, 2020 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - PIRAMAL ENTERPRISES COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS